Isabel Bahm, PhD, joined LSP in 2018 as an Analyst. Isabel provides in-depth analytical support to the LSP investment team, with a prime focus on LSP’s investment activities in the public equity franchise. Before joining LSP, Isabel was an Analyst in the health care team at M Ventures, the corporate venture capital arm of the German pharmaceutical company Merck KGaA. At M Ventures, Isabel was involved in the entire investment process, from the initial screening of the deal flow, to the selection of the most interesting and innovative investment opportunities within that deal flow. Once selected, Isabel performed in-depth scientific and clinical due diligence on these companies for the purpose of assessing their future potential. Prior to joining M Ventures Isabel received her PhD from the University College London (UCL), UK, where she was part of the Wellcome Trust stem cell and developmental biology PhD program. Her PhD research was focused on embryonic stem cell migration, a model system to study the underlying mechanisms and signaling pathways of cancer metastasis. At LSP, Isabel will deploy her extensive skill set, based on her scientific expertise in molecular biology, fertility and oncology, her detailed knowledge of the health care space and her analytical expertise. Prior to her doctoral training Isabel was awarded her undergrad degree in biology with honors (Diplom rerum naturalium), from the University of Freiburg, Germany. Isabel authored several papers and received prizes for her achievements during her undergrad and PhD. Isabel lives in Amsterdam with her husband.